Welcome to our dedicated page for Monday.Com Ltd. SEC filings (Ticker: MNDY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Monday.com Ltd. converts recurring subscriptions and multi-year deferred revenue into a fast-growing SaaS engine鈥攂ut the supporting details hide deep inside SEC disclosures. If you have searched for 鈥淢onday.com insider trading Form 4 transactions鈥� or 鈥淢onday.com quarterly earnings report 10-Q filing,鈥� this page delivers every document, already decoded.
Stock Titan鈥檚 AI gives you Monday.com SEC filings explained simply. The instant a 10-Q hits EDGAR, our system generates plain-English highlights, compares cohort expansion to prior quarters, and notes changes in deferred revenue. Form 4 insider transactions real-time alerts flag each executive trade, while AI clarifies whether it鈥檚 option vesting or an open-market purchase.
Here鈥檚 what you can explore:
- Annual report 10-K simplified鈥攔evenue recognition policy, R&D spend, geographic ARR trends
- Monday.com earnings report filing analysis鈥攁ll 10-Qs with side-by-side metric tracking
- Monday.com proxy statement executive compensation鈥攂onus targets and option grant history
- Monday.com 8-K material events explained鈥攑artnerships, offerings, leadership changes
- Monday.com executive stock transactions Form 4鈥攚ho bought or sold, and why it matters
Whether you鈥檙e building a discounted cash-flow model or monitoring product-led growth, understanding Monday.com SEC documents with AI saves hours. AG真人官方-time updates, comprehensive coverage of every form type, and expert commentary mean critical information reaches you before the market digests it.
monday.com Ltd. (MNDY) 鈥� Form 144 filing
The notice discloses that shareholder Aviad Eyal intends to sell 6,249 common shares of monday.com through Goldman Sachs & Co. LLC on or about 07 July 2025. At the most recent market price used in the filing, the proposed sale is valued at $1.91 million. The company has 50,773,337 shares outstanding, so the planned disposition represents roughly 0.012 % of outstanding stock.
During the last three months, the same seller reported three prior transactions totaling 6,253 shares for gross proceeds of $1.69 million. When aggregated with the planned sale, the 90-day total reaches 12,502 shares (about 0.025 % of shares outstanding), remaining well below the 1 % and volume thresholds typically used to assess Rule 144 activity.
No purchase-price debt, gifts, or special payment arrangements are disclosed. The filer certifies no undisclosed material adverse information and indicates compliance with Rule 10b5-1 if applicable.
Investment view: The notice signals limited insider selling. The share count and value are small relative to the company鈥檚 float and are unlikely to exert meaningful market pressure absent additional sales.
JPMorgan Chase Financial Company LLC is offering $1.25 million of Uncapped Buffered Return Enhanced Notes (UBRENs) maturing 28 June 2029 and linked to the lesser-performing of the EURO STOXX 50庐 (SX5E) and MSCI EAFE庐 (MXEA) indices. The notes are unsecured, unsubordinated obligations of JPMorgan Chase Financial and are fully and unconditionally guaranteed by JPMorgan Chase & Co.
Key structural terms
- Upside exposure: investors receive 2.174脳 any positive return of the weaker index at maturity; the return is uncapped.
- 30 % downside buffer: first 30 % index decline is absorbed; below that, losses accelerate at a 1.42857脳 rate.
- No interim coupons; payment only at maturity (5-year term).
- Issue price: $1,000 per note; estimated value $977.90 (reflecting selling commissions and hedging costs).
- Fees & commissions: $3.00 (0.30 %) per $1,000; net proceeds $997 per note.
- Credit exposure: repayment depends on JPMorgan Chase Financial and JPMorgan Chase & Co. creditworthiness.
- CUSIP: 48136E3C7; pricing date 24 June 2025; settlement on/around 27 June 2025.
Pay-out scenarios
- Positive: If both indices finish above their initial levels, investors earn 2.174脳 the lesser index鈥檚 gain (e.g., a 10 % gain delivers 21.74 %, or $1,217.40).
- Par: If either index declines 鈮� 30 % (or one rises and the other is 鈮� 30 % down), principal is repaid.
- Negative: If either index falls > 30 %, investors lose 1.42857 % for each additional 1 % drop; a 60 % decline cuts principal by 42.857 % to $571.43.
Risk highlights
- Principal at risk: losses begin beyond the 30 % buffer and can reach 100 %.
- Lesser-performer dependence: even strong performance in one index cannot offset weakness in the other.
- Secondary-market liquidity: the notes are unlisted; resale depends on J.P. Morgan Securities鈥� bid and may be at a substantial discount.
- Valuation gap: estimated value is 2.21 % below issue price, implying negative carry at issuance.
- Currency & foreign-market risks: both indices comprise non-U.S. equities; MXEA returns are translated into USD, adding FX exposure.
- Change-in-law acceleration: issuer may redeem early at a discretionary fair value if regulatory changes impede hedging.
Tax treatment 鈥� Counsel (Davis Polk) believes the notes should be treated as open transactions; gains held > 1 year generally taxed as long-term capital gain, but IRS guidance could change this stance retroactively.
Investor suitability 鈥� Product targets investors with a moderately bullish to neutral view on developed-market equities, tolerance for principal risk beyond a 30 % drawdown, and a willingness to hold to maturity without liquidity needs.
JPMorgan Chase Financial Company LLC is offering $1.25 million of Uncapped Buffered Return Enhanced Notes (UBRENs) maturing 28 June 2029 and linked to the lesser-performing of the EURO STOXX 50庐 (SX5E) and MSCI EAFE庐 (MXEA) indices. The notes are unsecured, unsubordinated obligations of JPMorgan Chase Financial and are fully and unconditionally guaranteed by JPMorgan Chase & Co.
Key structural terms
- Upside exposure: investors receive 2.174脳 any positive return of the weaker index at maturity; the return is uncapped.
- 30 % downside buffer: first 30 % index decline is absorbed; below that, losses accelerate at a 1.42857脳 rate.
- No interim coupons; payment only at maturity (5-year term).
- Issue price: $1,000 per note; estimated value $977.90 (reflecting selling commissions and hedging costs).
- Fees & commissions: $3.00 (0.30 %) per $1,000; net proceeds $997 per note.
- Credit exposure: repayment depends on JPMorgan Chase Financial and JPMorgan Chase & Co. creditworthiness.
- CUSIP: 48136E3C7; pricing date 24 June 2025; settlement on/around 27 June 2025.
Pay-out scenarios
- Positive: If both indices finish above their initial levels, investors earn 2.174脳 the lesser index鈥檚 gain (e.g., a 10 % gain delivers 21.74 %, or $1,217.40).
- Par: If either index declines 鈮� 30 % (or one rises and the other is 鈮� 30 % down), principal is repaid.
- Negative: If either index falls > 30 %, investors lose 1.42857 % for each additional 1 % drop; a 60 % decline cuts principal by 42.857 % to $571.43.
Risk highlights
- Principal at risk: losses begin beyond the 30 % buffer and can reach 100 %.
- Lesser-performer dependence: even strong performance in one index cannot offset weakness in the other.
- Secondary-market liquidity: the notes are unlisted; resale depends on J.P. Morgan Securities鈥� bid and may be at a substantial discount.
- Valuation gap: estimated value is 2.21 % below issue price, implying negative carry at issuance.
- Currency & foreign-market risks: both indices comprise non-U.S. equities; MXEA returns are translated into USD, adding FX exposure.
- Change-in-law acceleration: issuer may redeem early at a discretionary fair value if regulatory changes impede hedging.
Tax treatment 鈥� Counsel (Davis Polk) believes the notes should be treated as open transactions; gains held > 1 year generally taxed as long-term capital gain, but IRS guidance could change this stance retroactively.
Investor suitability 鈥� Product targets investors with a moderately bullish to neutral view on developed-market equities, tolerance for principal risk beyond a 30 % drawdown, and a willingness to hold to maturity without liquidity needs.
monday.com Ltd. (MNDY) filed a Form 144, indicating the proposed sale of 699 ordinary shares through Oppenheimer & Co. on or about 30 June 2025. Based on the filing鈥檚 stated aggregate market value of $215,264, the prospective sale represents less than 0.002% of the company鈥檚 50.8 million shares outstanding, implying minimal dilution or market impact. The shares were originally acquired on 14 Feb 2021 via an employee stock-option plan and will be sold for cash upon exercise. Over the last three months, the same insider鈥攊dentified as Nawi Shiran鈥攈as already sold 828 shares for gross proceeds of $255,327. No additional financial metrics, earnings data, or corporate developments are disclosed in this notice; the document solely reports the insider鈥檚 intent to dispose of a small position in compliance with SEC Rule 144.
monday.com has announced its Annual General Meeting of Shareholders scheduled for July 31, 2025, at 6:00 p.m. (Israel time) to be held at the company's Tel Aviv offices. The company has filed a Form 6-K to furnish the notice, proxy statement, and proxy card for the upcoming meeting.
Key documents furnished with this filing include:
- Notice and proxy statement detailing proposals to be voted upon and voting procedures (Exhibit 99.1)
- Proxy card for shareholder voting (Exhibit 99.2)
The Form 6-K has been incorporated by reference into the company's existing registration statements, including multiple S-8 forms (File Nos. 333-256964, 333-263614, 333-270515, 333-277913, and 333-285845) and Form F-3 (File No. 333-277915). The filing was executed by Shiran Nawi, Chief People and Legal Officer.